Shingles Vaccine Offers Hope Against Dementia
Vaccines that help prevent the devastating disease shingles could also offer a boon against cognitive decline. In a new study published Thursday, scientists have found that the latest shingles vaccine,…
Vaccines that help prevent the devastating disease shingles could also offer a boon against cognitive decline. In a new study published Thursday, scientists have found that the latest shingles vaccine,…
Study raises hopes that shingles vaccine may delay onset of dementia The Guardian Evidence mounts that shingles vaccines protect against dementia New Scientist NHS shingles vaccine could halt dementia –…
Trump echoes Kennedy’s vaccine conspiracies in leaked phone call Axios Trump met with Robert F. Kennedy Jr. to seek endorsement POLITICO In Leaked Phone Call, Trump Tries to Coax Kennedy…
People 6 months old and older should update their COVID-19 and flu shots this fall, the Centers for Disease Control and Prevention announced Thursday. The unanimous vote by a CDC…
Zoom In IconArrows pointing outwards Merck’s new pneumococcal vaccine. Courtesy: Merck The Food and Drug Administration on Monday approved Merck‘s new vaccine designed to protect adults from a bacteria known…
The Food and Drug Administration on Monday approved Merck‘s new vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and a lung infection…
{{#rendered}} {{/rendered}} The U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain of…
Moderna’s combined coronavirus-influenza shot produced a higher immune response in older adults than separate vaccines for those viruses administered together, according to data the company released Monday. The promising results…
Image source, Getty Images Image caption, A single dose should protect against Covid and flu Article information Author, Michelle Roberts Role, Digital health editor, BBC News 1 hour ago Drug…
Moderna plans to file for regulatory approval for its combination jab this summer in the U.S. and hopes it can enter the market in 2025, the company’s CEO Stephane Bancel…